pharmaphorum December 30, 2025
A federal judge in the US has granted a temporary restraining order that will stop HHS’ much-contested 340B rebate model from launching as planned on 1st January.
Judge Lance Walker sided with the American Hospital Association (AHA) and other plaintiffs in the lawsuit, brought in a Maine district court, which claims that the new model was unlawful and would add “hundreds of millions” of dollars to the annual costs of hospitals serving some of the most vulnerable people in the US.
The 340B drug discount programme requires pharma companies to discount outpatient drug sales to ‘safety net’ healthcare systems that serve uninsured and low-income patients. At the moment, these discounts are applied upfront, but pharma companies have been pushing for...
Today's Sponsors
Today's Sponsor